The reduction in Nanog, SOX2, and Oct4 protein expression levels suggests that hinokitiol may inhibit the stemness properties of breast cancer cells by suppressing the key regulators of stemness and the modulation of self-renewal and differentiation in cancer progression. Here, SOX2 is linked to breast carcinoma.